Funds holding Tianjin Pharmaceutical Da Re Tang Group Corp Ltd
ISIN CNE000001808 · China · LEI 300300KHA32RYXJS8249
- Fund holders
- 18
- Of which ETFs
- 9 9 other funds
- Value held
- 8.4M $ 11.3M SEK
This issuer has other securities : Tianjin Zhongxin Pharmaceutical Group Co., Ltd. (CNE100000924)
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 568,168 | 3.4M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 525,229 | 3.1M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Handelsbanken Global Index Criteria Handelsbanken Fonder AB | 183,200 | 10.3M SEK | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 147,458 | 878.4K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 56,221 | 334.9K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 30,800 | 183.5K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Core Equity Market ETF Dimensional ETF Trust | 26,900 | 159.8K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| THE EMERGING MARKETS SERIES DFA INVESTMENT TRUST CO | 26,400 | 157.3K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Handelsbanken Emerging Markets Index Handelsbanken Fonder AB | 17,300 | 975.7K SEK | 0.01 % | as of Mar 31, 2026 ↗ |
| Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust | 11,100 | 66K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF DBX ETF Trust | 7,562 | 47.4K $ | 0.12 % | as of Feb 27, 2026 ↗ |
| JNL Emerging Markets Index Fund JNL Series Trust | 6,100 | 36.2K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust | 4,500 | 26.7K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Rayliant Wilshire NxtGen Emerging Markets Equity ETF ADVISORS' INNER CIRCLE III | 3,200 | 18.9K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF DBX ETF Trust | 1,110 | 7K $ | 0.01 % | as of Feb 27, 2026 ↗ |
| Franklin Emerging Market Core Dividend Tilt Index ETF Franklin Templeton ETF Trust | 700 | 4.1K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MarketBeta Total International Equity ETF Goldman Sachs ETF Trust II | 496 | 3.1K $ | 0.00 % | as of Feb 27, 2026 ↗ |
| Goldman Sachs MarketBeta Emerging Markets Equity ETF Goldman Sachs ETF Trust | 410 | 2.6K $ | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF DBX ETF Trust | 0.12 % | as of Feb 27, 2026 ↗ |
| Rayliant Wilshire NxtGen Emerging Markets Equity ETF ADVISORS' INNER CIRCLE III | 0.03 % | as of Mar 31, 2026 ↗ |
| Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF DBX ETF Trust | 0.01 % | as of Feb 27, 2026 ↗ |
| Franklin Emerging Market Core Dividend Tilt Index ETF Franklin Templeton ETF Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Global Index Criteria Handelsbanken Fonder AB | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.01 % | as of Apr 30, 2026 ↗ |
| Handelsbanken Emerging Markets Index Handelsbanken Fonder AB | 0.01 % | as of Mar 31, 2026 ↗ |
| JNL Emerging Markets Index Fund JNL Series Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| THE EMERGING MARKETS SERIES DFA INVESTMENT TRUST CO | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 16 | +1 | 1,416,354 | +1.4 % |
| 2026Q1 | 15 | 0 | 1,396,194 | -2.8 % |
| 2025Q4 | 15 | +1 | 1,435,694 | +1.3 % |
| 2025Q3 | 14 | 0 | 1,417,494 | -0.1 % |
| 2025Q2 | 14 | -1 | 1,418,314 | -1.8 % |
| 2025Q1 | 15 | 0 | 1,444,556 | -3.2 % |
| 2024Q4 | 15 | +2 | 1,491,797 | -0.2 % |
| 2024Q3 | 13 | 0 | 1,494,653 | -1.8 % |
| 2024Q2 | 13 | +1 | 1,522,031 | +613.1 % |
| 2024Q1 | 12 | -3 | 213,434 | -86.1 % |
| 2023Q4 | 15 | 1,535,031 |
Cite this page
Titelia. "Funds holding Tianjin Pharmaceutical Da Re Tang Group Corp Ltd". https://titelia.com/en/stocks/tianjin-pharmaceutical-da-re-tang-group-corp-ltd-CNE000001808